Related Experiment Video
Updated: Jan 26, 2026

08:16
Comparative Lesions Analysis Through a Targeted Sequencing Approach
Published on: November 5, 2019
7.2K
The rash that presents as target lesions
Ronni Wolf1, Jennifer L Parish2, Lawrence Charles Parish3
1The School of Medicine, Hebrew University, Jerusalem, Israel; Hadassah Medical Center, Jerusalem, Israel.
Clinics in Dermatology
|April 15, 2019
Summary
This study classifies target lesions to help diagnose Stevens-Johnson syndrome/toxic epidermal necrolysis. It provides a diagnostic approach for clinicians to distinguish severe conditions from common skin ailments.
Area of Science:
- Dermatology
- Internal Medicine
Background:
- Target lesions are characteristic of severe mucocutaneous diseases.
- Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening conditions presenting with targetoid rashes.
Purpose of the Study:
- To systematically classify target lesions.
- To develop a diagnostic algorithm for differentiating SJS/TEN from other conditions presenting with targetoid lesions.
Main Methods:
- Clinical pattern analysis of target lesions.
- Classification based on lesion morphology (flat/raised, typical/atypical).
- Correlation with clinical features (fever, mucosal ulcerations, arthralgias) and systemic involvement.
Main Results:
- Detailed categorization of target lesions is presented.
- Specific clinical and histological features are associated with SJS/TEN.
- An algorithmic approach aids in diagnosis.
Conclusions:
- A structured approach to evaluating target lesions is crucial for timely SJS/TEN diagnosis.
- Differentiating SJS/TEN from benign conditions requires careful assessment of specific clinical and pathological findings.
Related Concept Videos
Targeted Cancer Therapies
8.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.7K
Targets for Drug Action: Overview
10.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.1K
Target Cell Response to Hormones
5.3K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
5.3K
Pedigree Analysis
89.0K
Overview
89.0K
Translesion DNA Polymerases
11.1K
Translesion (TLS) polymerases rescue stalled DNA polymerases at sites of damaged bases by replacing the replicative polymerase and installing a nucleotide across the damaged site. Doing so, TLS allows additional time for the cell to repair the damage before resuming regular DNA replication.
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
11.1K
Nucleotide Excision Repair
40.6K
Overview
40.6K

